Table of Contents

• Trial overview
• Conditions being studied
• Who can participate
• Trial phases and study designs
• Main endpoints and outcomes
• Key studies using Saline
• What these trials mean for patients

Trial overview

Across the trials provided, Saline is used mainly as a placebo or comparison treatment, not as the main study drug.^[1] The studies are testing many different treatments against Saline in areas such as lung disease, infection, cancer, diabetes, surgery, pain, and immune-related disease.^[2] Most of the trials are interventional, which means researchers assign treatments and then measure what happens.^[3]

Conditions being studied

The trials cover a wide range of conditions. These include chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, respiratory syncytial virus, obesity, early symptomatic Alzheimer’s disease, pancreatic cancer, advanced chronic ischemia with risk of amputation, ovarian cancer, alpha-1 antitrypsin deficiency-associated liver disease, anal fistula, alcohol use disorder, Dupuytren disease, presymptomatic type 1 diabetes, and postoperative pain or blood loss in surgery.^[1][2]

Some studies focus on adults only, such as the RSV vaccine study in immunocompromised patients aged 18 years and older.^[3] Other studies include children, such as the trial in pediatric patients with presymptomatic type 1 diabetes and the study of blood loss in pediatric hip surgery.^[4][5]

Who can participate

Who can join depends on the disease and the study goal. Some trials recruit people with a specific illness, such as COPD, metastatic pancreatic cancer, or alpha-1 antitrypsin deficiency-associated liver disease.^[1][6]

Other studies recruit healthier volunteers or people in a broader group. For example, one trial includes healthy adult participants for propofol injection pain, and another includes healthy volunteers to study liraglutide effects on gut movement and hunger.^[7][8]

Some studies also have special target groups, such as immunocompromised patients, older adults aged 80 years and above, or children with diabetes or surgical needs.^[3][9][4]

Trial phases and study designs

The data include Phase 1, Phase 2, Phase 3, and one Low Intervention study.^[10] Phase 2 trials are common in the list and are used to look more closely at whether a treatment works and to continue safety testing.^[10] Phase 3 trials are also common and usually compare treatments in larger groups to confirm benefit and safety.^[10]

Several trials are randomized, blinded, or placebo controlled. These designs help reduce bias by making comparisons fairer between the active treatment and Saline.^[11]

Main endpoints and outcomes

The primary endpoints vary by study. Some trials measure immune response, such as changes in cytokine production in COPD or interferon-gamma response after vaccination.^[1][12]

Other trials measure clinical outcomes that matter to patients, including overall survival in metastatic pancreatic cancer, progression-free survival in ovarian cancer, days alive and out of hospital in pneumonia, pain scores after surgery, blood loss during surgery, and scar quality after wound healing.^{[6][2][5][13]}

Some studies focus on safety and tolerability, such as the trials in early symptomatic Alzheimer’s disease and alpha-1 antitrypsin deficiency-associated liver disease.^[14][15] Others measure functional change, such as walking distance, ankle/brachial index, sperm concentration, muscle strength, insulin sensitivity, or time until rescue pain medicine is needed.^[16][17][18]

Key studies using Saline

In the COPD vaccine study, Saline is part of a Phase 2 trial that compares vaccination effects on innate immune training, which means the early part of the immune system is being studied for stronger responses after stimulation.^[1] In the pneumonia study, Saline is part of a Phase 2 strategy comparing inhaled levofloxacin with standard intravenous antibiotics, and the main result is days alive and out of hospital at 14 days.^[2]

In the RSV vaccine study, immunocompromised adults receive Saline or the vaccine, and the main endpoint is the fold increase in RSV-A and RSV-B neutralizing titers, which are antibodies that can block the virus.^[3] In the pancreatic cancer trial, Saline is the placebo arm in a large Phase 3 study measuring overall survival.^[6]

In the diabetes and immune studies, Saline is used in trials that look at whether treatment can keep children in stage 1 type 1 diabetes and how many adverse events occur over time.^[4] In the surgery and pain studies, Saline is used to compare pain relief, blood loss, and nerve block effects after procedures.^[5][13][19]

What these trials mean for patients

These studies show that Saline is being used as a comparison treatment across many medical fields.^[1] The goal is not to study Saline itself as a treatment, but to see whether the active study drug or procedure works better than Saline.^[11]

For patients, this means the trial may be looking at whether a vaccine, medicine, block, infusion, or surgery-related treatment improves outcomes compared with a placebo control.^[2][13] The important results vary by condition, but they often include symptoms, recovery, safety, and longer-term health changes.^[14][15]